Concepedia

Laura Catena

LC

24

Publications

1.3K

Citations

19

H-Index

1991

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

European Institute of Oncology

Istituti di Ricovero e Cura a Carattere Scientifico

Fondazione Lanza

Azienda Ospedaliero-Universitaria Careggi

Laura Catena is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1991–2018

24

Publications

24

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Emilio Bajetta, Laura Catena, Giuseppe Procopio et al. · Cancer Chemotherapy and Pharmacology · 2006 · 241 citations

, , +7

Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

Emilio Bajetta, Giuseppe Procopio, Luigi Celio et al. · Journal of Clinical Oncology · 2005 · 208 citations · Full text

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Emilio Bajetta, L. Ferrari, Giuseppe Procopio et al. · Annals of Oncology · 2002 · 113 citations · Full text

, , +8

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 87 citations · Full text

, , +8

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

Emilio Bajetta, Laura Catena, Giuseppe Procopio et al. · Annals of Oncology · 2005 · 76 citations · Full text

, , +10

Rows per page

1–5 of 24